Second, we demonstrated independent associations between galectin-1, alpha-1-microglobulin, and galectin-9 and 2-year MACE in the patients with PAD after controlling for the baseline demographic and clinical characteristics, including existing CAD and CVD. This evidence concerns the gene LGALS9 and peripheral arterial disease.